• Corpus ID: 24713945

Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.

@article{Mitzner2001ExtracorporealDU,
  title={Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.},
  author={Steffen R. Mitzner and Jan Stange and Sebastian Klammt and Piotr Peszynski and Reinhardt Schmidt and Gabriele N{\"o}ldge-Schomburg},
  journal={Journal of the American Society of Nephrology : JASN},
  year={2001},
  volume={12 Suppl 17},
  pages={
          S75-82
        }
}
Liver failure resulting from different causes and its concomitant complications represent difficult-to-treat conditions with high mortality rates, despite improved therapeutic modalities in intensive care medicine. The accumulation of albumin-bound metabolites that are normally cleared by the liver, such as bilirubin and bile acids, contributes substantially to the development of multiorgan dysfunction in these clinical situations. The molecular adsorbent recirculating system (MARS) represents… 

Figures and Tables from this paper

The Molecular Adsorbent Recirculating System (MARS®) in the intensive care unit: a rescue therapy for patients with hepatic failure
TLDR
It is a major improvement in the management of patients with hepatic failure that could permit, when appropriately indicated, recovery from an acute episode and enhance the chances of survival while waiting for an available organ donor.
Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy.
  • S. Ash
  • Medicine, Biology
    Advances in renal replacement therapy
  • 2002
TLDR
Clinical results of daily MARS treatments of patients with hepatic failure are similar to that of Liver Dialysis, with neurologic and physical improvement occurs in most patients with AHE, and improved outcome for patientsWith A-on-C.
[MARS (Molecular Absorbent Recirculating System) as hepatic extracorporeal care in serious acute liver failure of alcoholic etiology].
TLDR
MADS (Molecular Adsorbent recirculating System) is introduced as a extracorporeal liver assistance system with detoxification function, that is presented as a support measure that makes it possible to maintain the patient in good conditions until an organ becomes available or until the functional recovery of the native liver.
Equipment review: The molecular adsorbents recirculating system (MARS®)
TLDR
Preliminary experience with MARS therapy, instituted late in the clinical course of five patients with severely impaired liver function, indicates some clinical efficacy, but the overall survival rate remained poor and the overall impact on outcome remained poor.
Sorbent Suspension Reactor for Extracorporeal Detoxification in Hepatic Failure or Drug Overdose
TLDR
Activated carbon hemoperfusion columns were introduced in an attempt to improve toxin removal efficacy compared to hemodialysis and provide selectivity in chemical removal.
The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure
TLDR
The Molecular Adsorbents Recirculating System (MARS) is an extracorporeal liver support device based on dialysis across an albumin-impregnated membrane, using 20% albumin as dialysate and charcoal and anion exchange resin columns in the circuit help cleanse and regenerate the dialysates.
Commentary The Molecular Adsorbent Recirculating System (MARS ® ) in the intensive care unit: a rescue therapy for patients with hepatic
TLDR
It is a major improvement in the management of patients with hepatic failure that could permit, when appropriately indicated, recovery from an acute episode and enhance the chances of survival while waiting for an available organ donor.
Review article: the Molecular Adsorbents Recirculating System (MARS) in liver failure
TLDR
Although the clinical experience with MARS is scarce, some pilot studies have reported its effectiveness at improving liver function and hepatic encephalopathy in patients with acute decompensation of chronic liver disease, and renal function in patientswith hepatorenal syndrome type I.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 68 REFERENCES
Liver support by extracorporeal blood purification: A clinical observation
  • J. Stange, S. Mitzner, U. Hopt
  • Medicine, Biology
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2000
TLDR
It is concluded that in acute excretory failure caused by a chronic liver disease, this treatment provides a therapy option to remove toxins involved in multiorgan dysfunction secondary to liver failure.
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial
  • S. Mitzner, J. Stange, R. Schmidt
  • Medicine
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2000
TLDR
It is concluded that the removal of albumin‐bound substances with the MARS method can contribute to the treatment of type I HRS.
Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support.
TLDR
A new membrane separation system that is nearly impermeable to proteins but enables the exchange of water soluble and protein bound toxins by a special membrane and a recycled protein containing dialysate is described.
Extracorporeal perfusion for the treatment of acute liver failure.
TLDR
Renewed interest has developed in old and new methods for an extracorporeal approach to the treatment of acute liver failure and further research is needed to achieve a successful long-term clinical outcome.
A Carrier-Mediated Transport of Toxins in a Hybrid Membrane. Safety Barrier between a Patients Blood and a Bioartificial Liver
TLDR
The presented hybrid membrane may be used like an “intellegent membrane” as a safety barrier between the patients blood and cell devices and a significant reduction of protein bound toxins and a transport of metabolically relevant solutes, like amino acids, was shown.
Liver transplantation for acute liver failure.
TLDR
The decision for liver transplantation should be based on prognostic criteria, including patient's age, aetiology of liver disease, degree and onset of encephalopathy, serum bilirubin, prothrombin time or international normalized ratio, serum creatinine, factor V level and arterial pH.
Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure.
TLDR
Treatment by hemoperfusion with an extracorporeal liver assist device (ELAD) containing human liver-derived cells was performed in 12 patients with acute liver failure, and there was no evidence of the clearance of cytokines by the ELAD.
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
TLDR
In patients with cirrhosis and spontaneous bacterial peritonitis, treatment with intravenous albumin in addition to an antibiotic reduces the incidence of renal impairment and death in comparison with treatment with an antibiotic alone.
...
1
2
3
4
5
...